NU RIDE INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NU RIDE INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($619.0K) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($8.14M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($343.07M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($282.40M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($410.37M) | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | ($124.05M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | ($10.39M) | Feb 28, 2022 |
| FY2019 | Dec 31, 2018 | ($1.7K) | Mar 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.76M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($10.89M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($348.90M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($387.30M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($400.49M) | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | ($102.28M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | ($10.39M) | Feb 28, 2022 |
| FY2019 | Dec 31, 2018 | ($1.7K) | Mar 25, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $33.34M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $107.82M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $284.02M | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | $70.97M | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $5.87M | Feb 28, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.77M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $12.90M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $54.41M | Mar 28, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.23M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($35.08M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($137.17M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($213.76M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($387.99M) | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | ($99.60M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | ($5.20M) | Feb 28, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $10.15M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $54.57M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $284.51M | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | $52.65M | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $133.0K | Feb 28, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $46.97M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $53.18M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $92.17M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $452.31M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $688.78M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $767.22M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $33.55M | Jun 8, 2021 |
| FY2019 | Dec 31, 2018 | $120.0K | Mar 25, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.00M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $10.95M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $45.87M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $70.28M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $149.18M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $136.48M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $24.99M | Jun 8, 2021 |
| FY2019 | Dec 31, 2018 | $96.7K | Mar 25, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.60M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $6.78M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $13.55M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $351.77M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $539.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $630.74M | Mar 6, 2023 |
| FY2022 | Dec 31, 2019 | $8.56M | Mar 6, 2023 |
| FY2021 | Apr 29, 2019 | $0 | Feb 28, 2022 |
| FY2019 | Dec 31, 2018 | $23.4K | Mar 25, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.18B) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($1.18B) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($1.17B) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($827.21M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($544.81M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($134.44M) | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | ($10.39M) | Jun 8, 2021 |
| FY2019 | Dec 31, 2018 | ($1.7K) | Mar 25, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.44M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $23.10M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $87.10M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $121.36M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $244.02M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $629.76M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $2.16M | Jun 8, 2021 |
| FY2019 | Dec 31, 2018 | $20.0K | Mar 25, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | (21) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | (20) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | (1) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | (21) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | (20) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | (1) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 28, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 15.95M | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | 15.93M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 196.39M | Mar 6, 2023 |
| FY2022 | Dec 31, 2020 | 168.00M | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | 68.30M | Feb 28, 2022 |